Bullish
Xeris Biopharma (NASDAQ: XERS) to retire $23M of 8% notes in cash-and-stock deal
Xeris Biopharma Holdings has entered into agreements to retire approximately $23 million of its 8.00% Convertible Senior Notes due 2028 through a cash...
